drugset / Trial / NCT00004446
Study of Fluoxetine in Patients With Depersonalization Disorder
Completed
80 enrolled
National Institute of Mental Health (NIMH)
Icahn School of Medicine at Mount Sinai · collab
RandomizedDouble-blindTreatment
Summary
The purpose of this study is to: 1\) Determine the effects of fluoxetine in the treatment of depersonalization disorder, 2) Assess the durability of treatment response in these patients, 3) Assess the improvement in psychiatric disability in these patients, and 4) Assess the effects of comorbid Axis I disorders (depression, social phobia, panic/anxiety, obsessive-compulsive disorder) and Axis II personality disorders on treatment outcome in these patients.
Timeline
- Start
- 1998-04
- Primary completion
- —
- Completion
- —
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | — | — |